Groups information

Group name

MP-RARP

BCR
Continence

Continence

3 (7.3)

p-value

0.97

remark

2-4, Continence status—pads/day, n (%)

Sexual Function
PSA

PSA

33 (82.5)

p-value

0.28

remark

Undetectable-PSA status, n (%)

Complications or other prognosis
Positive surgical margin (PSM)
Other quality of life
Surgical related outcomes
Survival Outcome
Survival Outcome
Other outcomes
Follow Up Time

Follow Up Time

12-mo